金地商置集團有限公司（「本公司」）董事會（「董事會」）謹此宣佈將於2025年8 月22日舉行董事會會議，以考慮及批准（其中包括）本公司及其附屬公司截至2025 年6月30日止六個月之未經審核中期業績及其發佈，以及處理任何其他事項（如 有）。 承董事會命 金地商置集團有限公司 執行董事 徐家俊 香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈的內容概不負責，對其準確性或 完整性亦不發表任何聲明，並明確表示概不就因本公佈全部或任何部分內容而產生或因依賴該等 內容而引致的任何損失承擔任何責任。 Gemdale Properties and Investment Corporation Limited 金地商置集團有限公司* （於百慕達註冊成立之有限公司） （股份代號：535） 董事會會議通告 香港，2025年8月12日 於本公佈日期，董事會成員包括四名執行董事黃俊燦先生、徐家俊先生、李榮輝先生及韋傳軍先 生；兩名非執行董事 Loh Lian Huat 先生及張斐贇女士；以及三名獨立非執行董事許照中先生、 蔣尚義先生及夏新平先生。 * 僅供識別 C:\C S\Quarterly Results\1Q-07-0 ...

Performance Highlights - BeiGene (06160.HK) reported a revenue of 17.518 billion yuan for the first half of the year, a year-on-year increase of 46%; product revenue was 17.36 billion yuan, up 45.8%; net profit was 450 million yuan, turning from loss to profit [2] - Uni-President China (00220.HK) achieved approximately 17.087 billion yuan in revenue for the first half, a year-on-year increase of 10.6%; net profit was about 1.287 billion yuan, up 33.2% [2] - Zhiyu City Technology (09911.HK) announced a positive profit forecast, expecting mid-term revenue of approximately 3.135 to 3.215 billion yuan, a year-on-year increase of about 38.0% to 41.5%; net profit is expected to be around 470 to 510 million yuan, a year-on-year growth of approximately 108.9% to 126.7% [2] Earnings Forecasts - New World Development Company (00086.HK) expects mid-term net profit to increase to no less than 800 million HKD year-on-year [3] - Weizhi Jinkou (02003.HK) anticipates mid-term net profit exceeding 200 million HKD, a significant increase year-on-year [3] - Wing Chan Industrial (01596.HK) forecasts mid-term net profit of approximately 48.7 million HKD, turning from loss to profit [3] - Huaxian Optoelectronics (00334.HK) expects mid-term net profit to exceed 48.8 million HKD, a year-on-year increase of over 600% [3] - Maifushi (02556.HK) predicts mid-term net profit of approximately 31.8 to 41 million HKD, turning from loss to profit [4] - Xinwei Medical-B (06609.HK) expects mid-term net profit to exceed 40 million HKD, turning from loss to profit [5] - China Nuclear Technology (00611.HK) anticipates mid-term net profit growth of over 15% [6] Earnings Warnings - Hongxing Printing Group (00450.HK) expects mid-term net loss of approximately 49 million HKD, a significant increase year-on-year [7] - Zhongyu Land (01224.HK) forecasts mid-term net loss of approximately 40 million HKD, turning from profit to loss [7] - Beihai Group (00701.HK) anticipates mid-term net loss of 36 to 40 million HKD [8] Real Estate Sales Data - China Overseas Development (00688.HK) reported cumulative contract property sales of approximately 132 billion yuan for the first seven months, a year-on-year decrease of 18.3% [9] - Yuexiu Property (00123.HK) achieved cumulative contract sales of approximately 67.506 billion yuan for the first seven months, a year-on-year increase of about 11.7% [9] - Poly Property Group (00119.HK) reported contract sales of approximately 29.5 billion yuan for the first seven months, a year-on-year decrease of 13.49% [10] - China Overseas Hongyang Group (00081.HK) reported cumulative contract sales of 18.649 billion yuan for the first seven months, a year-on-year decrease of 12.2% [10] - Jindi Commercial Real Estate (00535.HK) reported cumulative contract sales of approximately 6.98 billion yuan for the first seven months, a year-on-year decrease of 37.37% [10] - Agile Group (03383.HK) reported pre-sale amount of approximately 5.69 billion yuan for the first seven months [11] - Hongyang Real Estate (01996.HK) reported cumulative contract sales of 3.208 billion yuan for the first seven months, a year-on-year decrease of 41.6% [12] - Zhengrong Real Estate (06158.HK) reported cumulative contract sales of approximately 2.701 billion yuan for the first seven months, a year-on-year decrease of 30.6% [12] - Jingrui Holdings (01862.HK) reported cumulative contract sales of approximately 571 million yuan for the first seven months, a year-on-year decrease of 52.54% [13] Company News - CITIC Securities (06030.HK) reported that its subsidiary, Huaxia Fund, achieved revenue of 4.258 billion yuan and net profit of 1.123 billion yuan in the first half, with assets under management totaling 285.1237 billion yuan [14] - Xinyi International (00732.HK) reported a cumulative operating revenue of approximately 9.566 billion HKD for the first seven months, a year-on-year decrease of about 5.3% [15] - Heng Rui Pharmaceutical (01276.HK) received orphan drug designation from the US FDA for its injection of Rikan Trastuzumab combined with Adebali for gastric cancer or gastroesophageal junction adenocarcinoma indications [15] - Fuhong Hanlin (02696.HK) completed the first patient dosing in a Phase II clinical study of HLX79 injection combined with Hanlikang® for active renal glomerulonephritis in China [15] - China Biopharmaceutical (01177.HK) announced that its self-developed TQ05105 (JAK/ROCK inhibitor) has been included in the breakthrough therapy designation program for the treatment of chronic graft-versus-host disease [15] Buyback Activities - HSBC Holdings (00005.HK) repurchased approximately 1.65 billion HKD worth of about 1.714 million shares at a price of 95.8 to 96.75 HKD [16] - Hang Seng Bank (00011.HK) spent approximately 22.6347 million HKD to repurchase 200,000 shares at a price of 112.8 to 113.6 HKD [17] - Yum China (09987.HK) repurchased approximately 6.264 million HKD worth of 16,800 shares at a price of 369.8 to 376 HKD [17]

Core Viewpoint - The company reported its contract sales figures for July 2025, indicating a total contract sales amount of approximately RMB 1.28 billion and a sales area of about 90,400 square meters, with an average selling price of around RMB 14,200 per square meter [1] Summary by Relevant Sections - **Contract Sales for July 2025** - The total contract sales amount for July 2025 was approximately RMB 1.28 billion [1] - The total sales area for the same period was about 90,400 square meters [1] - The average selling price during this period was around RMB 14,200 per square meter [1] - **Cumulative Contract Sales from January to July 2025** - The cumulative contract sales amount from January to July 2025 reached approximately RMB 6.98 billion [1] - The cumulative sales area for this period was about 542,700 square meters [1]

Group 1 - The core point of the article is that the company, Gindalbie Metals (00535), reported a total contract sales amount of approximately 1.28 billion yuan for July 2025, representing a year-on-year decrease of 4.9% [1] - The total contract sales area during the same period was approximately 90,400 square meters, with an average sales price of about 14,200 yuan per square meter [1] - Cumulatively, from January to July 2025, the total contract sales amounted to approximately 6.98 billion yuan, reflecting a year-on-year decrease of 37.37%, with a total sales area of about 542,700 square meters [1]

Group 1 - The core viewpoint of the article indicates that the company, Jin Di Shang Zhi (00535), reported a total contract sales amount of approximately 1.28 billion yuan for July 2025, representing a year-on-year decrease of 4.9% [1] - The total contract sales area for the same period was approximately 90,400 square meters, with an average sales price of about 14,200 yuan per square meter [1] - Cumulatively, from January to July 2025, the total contract sales amount reached approximately 6.98 billion yuan, reflecting a significant year-on-year decrease of 37.37% [1] - The cumulative sales area during this period was approximately 542,700 square meters [1]

格隆汇8月6日丨金地商置(00535.HK)发布公告，集团于2025年7月的合约销售总额约人民币12.8亿元， 而期内合约销售总面积约9.04万平方米。期内的销售均价为每平方米约人民币14,200元。 自2025年1月至7月期间的累计合约销售总额约人民币69.8亿元，而累计销售总面积约54.27万平方米。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈的內容概不負責，對其準確性或完整性亦不發 表任何聲明，並明確表示概不就因本公佈全部或任何部分內容而產生或因依賴該等內容而引致的任何損失承擔 任何責任。 上述銷售數據未經審核，乃根據本集團初步內部資料編制，鑒於收集該等銷售資料過程中存 在各種不確定因素，該等銷售資料與本公司按年度或中期刊發的經審核或未經審核綜合財務 報表中披露的數字可能存在差異。因此，上述數據僅供投資者參考。本公司股東及潛在投資 者買賣本公司證券時務須謹慎行事，並避免不恰當地依賴該等資料。如有任何疑問，投資者 應尋求專業人士或財務顧問的專業意見。 承董事會命 金地商置集團有限公司 執行董事 徐家俊 香港，二零二五年八月六日 於本公佈日期，董事會成員包括四名執行董事黃俊燦先生、徐家俊先生、李榮輝先生及韋傳 軍先生；兩名非執行董事 Loh Lian Huat 先生及張斐贇女士，以及三名獨立非執行董事許照 中先生、蔣尚義先生及夏新平先生。 * 僅供識別 Gemdale Properties and Investment Corporation Limited 金地商置集團有限公司* （於百慕達註 ...

致：香港交易及結算所有限公司 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年7月31日 狀態: 新提交 公司名稱: 金地商置集團有限公司 呈交日期: 2025年8月1日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | 是 | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00535 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 40,000,000,000 | HKD | | 0.1 HKD | | | 4,000,000,000 | | 增加 / 減少 (-) | | | | | | HKD | | | | | 本月底結存 | | | 40,000,000,000 | HKD | | 0.1 HKD | | | 4,000,000,000 | 本月底法 ...

Core Viewpoint - The company, Gindal Group, is expected to report significant losses in the first half of 2025, with projected net profit attributable to shareholders ranging from -34 billion to -42 billion yuan, primarily due to declining sales and reduced revenue [1] Financial Performance - The projected net profit for the first half of 2025 is significantly worse than the previous year's figures, which were a net profit of -33.61 billion yuan and a total profit of -46.58 billion yuan [1] - The company anticipates a non-recurring net profit of -32 billion to -40 billion yuan for the same period in 2025, compared to -26.95 billion yuan in the previous year [1] Operational Challenges - The decline in sales scale and the reduction in transferable area are cited as key reasons for the expected losses [1] - The company has adjusted its operational and sales strategies in response to market conditions, leading to asset impairment provisions due to the net realizable value of some inventory being lower than cost [1] Strategic Initiatives - To address inventory issues, the company is pursuing asset revitalization measures, including land acquisition and exchange [1] - A recent project in Wuhan, which involved the acquisition of a school site through a housing reserve, achieved an 88% sales rate during its initial launch [1] Financing Efforts - The company is seeking to enhance cash flow to restore operations and has received investor approval to cancel the 2025 exit arrangement for a specific asset-backed plan [1] - Gindal Group is also working on financing options such as operational property loans and real estate asset-backed securities to secure additional cash [2]

Group 1 - The top three companies with the highest short positions are WuXi AppTec (22.57%), CATL (17.76%), and COSCO Shipping Holdings (14.27%) [1][2] - The companies with the largest absolute increase in short positions are Alibaba Health (4.45%), China Liansu (2.54%), and Hong Kong Travel (2.02%) [1][2] - The companies with the largest absolute decrease in short positions are Far East Horizon (-1.62%), ZhongAn Online (-1.55%), and Rongchang Biologics (-1.32%) [1][3] Group 2 - The latest short position data shows that WuXi AppTec has 87.35 million shares, CATL has 27.69 million shares, and COSCO Shipping Holdings has 411 million shares [2] - Alibaba Health's short position increased from 6.97% to 11.42%, while China Liansu's increased from 0.61% to 3.15% [2] - Far East Horizon's short position decreased from 4.43% to 2.82%, and ZhongAn Online's decreased from 7.43% to 5.88% [3][4]